Meningococcal Conjugate Market, Global Outlook and Forecast 2022-2028

March 2022 | 69 pages | ID: M334A411119FEN
Market Monitor Global

Abstracts

Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.

This report contains market size and forecasts of Meningococcal Conjugate in Global, including the following market information:

Global Meningococcal Conjugate Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Meningococcal Conjugate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Menactra Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Meningococcal Conjugate include Sanofi Pasteur, Pfizer, Glaxo Smith Kline, Hualan Biological Engineering, JN International Medical Corporation, Baxter International, Merck, Serum Institute of India and Biomed and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Meningococcal Conjugate companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Meningococcal Conjugate Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Meningococcal Conjugate Market Segment Percentages, by Type, 2021 (%)

• Menactra
• Menveo
• NeisVac-C
• Nimenrix
• Others

Global Meningococcal Conjugate Market, by End User, 2017-2022, 2023-2028 ($ millions)

Global Meningococcal Conjugate Market Segment Percentages, by End User, 2021 (%)

• Children
• Preteens or Teens
• Adults

Global Meningococcal Conjugate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Meningococcal Conjugate Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Meningococcal Conjugate revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Meningococcal Conjugate revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi Pasteur
• Pfizer
• Glaxo Smith Kline
• Hualan Biological Engineering
• JN International Medical Corporation
• Baxter International
• Merck
• Serum Institute of India
• Biomed
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Meningococcal Conjugate Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by End User
1.3 Global Meningococcal Conjugate Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MENINGOCOCCAL CONJUGATE OVERALL MARKET SIZE

2.1 Global Meningococcal Conjugate Market Size: 2021 VS 2028
2.2 Global Meningococcal Conjugate Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Meningococcal Conjugate Players in Global Market
3.2 Top Global Meningococcal Conjugate Companies Ranked by Revenue
3.3 Global Meningococcal Conjugate Revenue by Companies
3.4 Top 3 and Top 5 Meningococcal Conjugate Companies in Global Market, by Revenue in 2021
3.5 Global Companies Meningococcal Conjugate Product Type
3.6 Tier 1, Tier 2 and Tier 3 Meningococcal Conjugate Players in Global Market
  3.6.1 List of Global Tier 1 Meningococcal Conjugate Companies
  3.6.2 List of Global Tier 2 and Tier 3 Meningococcal Conjugate Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Meningococcal Conjugate Market Size Markets, 2021 & 2028
  4.1.2 Menactra
  4.1.3 Menveo
  4.1.4 NeisVac-C
  4.1.5 Nimenrix
  4.1.6 Others
4.2 By Type - Global Meningococcal Conjugate Revenue & Forecasts
  4.2.1 By Type - Global Meningococcal Conjugate Revenue, 2017-2022
  4.2.2 By Type - Global Meningococcal Conjugate Revenue, 2023-2028
  4.2.3 By Type - Global Meningococcal Conjugate Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Meningococcal Conjugate Market Size, 2021 & 2028
  5.1.2 Children
  5.1.3 Preteens or Teens
  5.1.4 Adults
5.2 By End User - Global Meningococcal Conjugate Revenue & Forecasts
  5.2.1 By End User - Global Meningococcal Conjugate Revenue, 2017-2022
  5.2.2 By End User - Global Meningococcal Conjugate Revenue, 2023-2028
  5.2.3 By End User - Global Meningococcal Conjugate Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Meningococcal Conjugate Market Size, 2021 & 2028
6.2 By Region - Global Meningococcal Conjugate Revenue & Forecasts
  6.2.1 By Region - Global Meningococcal Conjugate Revenue, 2017-2022
  6.2.2 By Region - Global Meningococcal Conjugate Revenue, 2023-2028
  6.2.3 By Region - Global Meningococcal Conjugate Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Meningococcal Conjugate Revenue, 2017-2028
  6.3.2 US Meningococcal Conjugate Market Size, 2017-2028
  6.3.3 Canada Meningococcal Conjugate Market Size, 2017-2028
  6.3.4 Mexico Meningococcal Conjugate Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Meningococcal Conjugate Revenue, 2017-2028
  6.4.2 Germany Meningococcal Conjugate Market Size, 2017-2028
  6.4.3 France Meningococcal Conjugate Market Size, 2017-2028
  6.4.4 U.K. Meningococcal Conjugate Market Size, 2017-2028
  6.4.5 Italy Meningococcal Conjugate Market Size, 2017-2028
  6.4.6 Russia Meningococcal Conjugate Market Size, 2017-2028
  6.4.7 Nordic Countries Meningococcal Conjugate Market Size, 2017-2028
  6.4.8 Benelux Meningococcal Conjugate Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Meningococcal Conjugate Revenue, 2017-2028
  6.5.2 China Meningococcal Conjugate Market Size, 2017-2028
  6.5.3 Japan Meningococcal Conjugate Market Size, 2017-2028
  6.5.4 South Korea Meningococcal Conjugate Market Size, 2017-2028
  6.5.5 Southeast Asia Meningococcal Conjugate Market Size, 2017-2028
  6.5.6 India Meningococcal Conjugate Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Meningococcal Conjugate Revenue, 2017-2028
  6.6.2 Brazil Meningococcal Conjugate Market Size, 2017-2028
  6.6.3 Argentina Meningococcal Conjugate Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Meningococcal Conjugate Revenue, 2017-2028
  6.7.2 Turkey Meningococcal Conjugate Market Size, 2017-2028
  6.7.3 Israel Meningococcal Conjugate Market Size, 2017-2028
  6.7.4 Saudi Arabia Meningococcal Conjugate Market Size, 2017-2028
  6.7.5 UAE Meningococcal Conjugate Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi Pasteur
  7.1.1 Sanofi Pasteur Corporate Summary
  7.1.2 Sanofi Pasteur Business Overview
  7.1.3 Sanofi Pasteur Meningococcal Conjugate Major Product Offerings
  7.1.4 Sanofi Pasteur Meningococcal Conjugate Revenue in Global Market (2017-2022)
  7.1.5 Sanofi Pasteur Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Meningococcal Conjugate Major Product Offerings
  7.2.4 Pfizer Meningococcal Conjugate Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Glaxo Smith Kline
  7.3.1 Glaxo Smith Kline Corporate Summary
  7.3.2 Glaxo Smith Kline Business Overview
  7.3.3 Glaxo Smith Kline Meningococcal Conjugate Major Product Offerings
  7.3.4 Glaxo Smith Kline Meningococcal Conjugate Revenue in Global Market (2017-2022)
  7.3.5 Glaxo Smith Kline Key News
7.4 Hualan Biological Engineering
  7.4.1 Hualan Biological Engineering Corporate Summary
  7.4.2 Hualan Biological Engineering Business Overview
  7.4.3 Hualan Biological Engineering Meningococcal Conjugate Major Product Offerings
  7.4.4 Hualan Biological Engineering Meningococcal Conjugate Revenue in Global Market (2017-2022)
  7.4.5 Hualan Biological Engineering Key News
7.5 JN International Medical Corporation
  7.5.1 JN International Medical Corporation Corporate Summary
  7.5.2 JN International Medical Corporation Business Overview
  7.5.3 JN International Medical Corporation Meningococcal Conjugate Major Product Offerings
  7.5.4 JN International Medical Corporation Meningococcal Conjugate Revenue in Global Market (2017-2022)
  7.5.5 JN International Medical Corporation Key News
7.6 Baxter International
  7.6.1 Baxter International Corporate Summary
  7.6.2 Baxter International Business Overview
  7.6.3 Baxter International Meningococcal Conjugate Major Product Offerings
  7.6.4 Baxter International Meningococcal Conjugate Revenue in Global Market (2017-2022)
  7.6.5 Baxter International Key News
7.7 Merck
  7.7.1 Merck Corporate Summary
  7.7.2 Merck Business Overview
  7.7.3 Merck Meningococcal Conjugate Major Product Offerings
  7.7.4 Merck Meningococcal Conjugate Revenue in Global Market (2017-2022)
  7.7.5 Merck Key News
7.8 Serum Institute of India
  7.8.1 Serum Institute of India Corporate Summary
  7.8.2 Serum Institute of India Business Overview
  7.8.3 Serum Institute of India Meningococcal Conjugate Major Product Offerings
  7.8.4 Serum Institute of India Meningococcal Conjugate Revenue in Global Market (2017-2022)
  7.8.5 Serum Institute of India Key News
7.9 Biomed
  7.9.1 Biomed Corporate Summary
  7.9.2 Biomed Business Overview
  7.9.3 Biomed Meningococcal Conjugate Major Product Offerings
  7.9.4 Biomed Meningococcal Conjugate Revenue in Global Market (2017-2022)
  7.9.5 Biomed Key News
7.10 Novartis
  7.10.1 Novartis Corporate Summary
  7.10.2 Novartis Business Overview
  7.10.3 Novartis Meningococcal Conjugate Major Product Offerings
  7.10.4 Novartis Meningococcal Conjugate Revenue in Global Market (2017-2022)
  7.10.5 Novartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Meningococcal Conjugate Market Opportunities & Trends in Global Market
Table 2. Meningococcal Conjugate Market Drivers in Global Market
Table 3. Meningococcal Conjugate Market Restraints in Global Market
Table 4. Key Players of Meningococcal Conjugate in Global Market
Table 5. Top Meningococcal Conjugate Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Meningococcal Conjugate Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Meningococcal Conjugate Revenue Share by Companies, 2017-2022
Table 8. Global Companies Meningococcal Conjugate Product Type
Table 9. List of Global Tier 1 Meningococcal Conjugate Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Meningococcal Conjugate Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Meningococcal Conjugate Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Meningococcal Conjugate Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Meningococcal Conjugate Revenue in Global (US$, Mn), 2023-2028
Table 14. By End User – Global Meningococcal Conjugate Revenue, (US$, Mn), 2021 & 2028
Table 15. By End User - Meningococcal Conjugate Revenue in Global (US$, Mn), 2017-2022
Table 16. By End User - Meningococcal Conjugate Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Meningococcal Conjugate Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Meningococcal Conjugate Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Meningococcal Conjugate Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Meningococcal Conjugate Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Meningococcal Conjugate Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Meningococcal Conjugate Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Meningococcal Conjugate Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Meningococcal Conjugate Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Meningococcal Conjugate Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Meningococcal Conjugate Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Meningococcal Conjugate Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Meningococcal Conjugate Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Meningococcal Conjugate Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Pasteur Corporate Summary
Table 31. Sanofi Pasteur Meningococcal Conjugate Product Offerings
Table 32. Sanofi Pasteur Meningococcal Conjugate Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Meningococcal Conjugate Product Offerings
Table 35. Pfizer Meningococcal Conjugate Revenue (US$, Mn), (2017-2022)
Table 36. Glaxo Smith Kline Corporate Summary
Table 37. Glaxo Smith Kline Meningococcal Conjugate Product Offerings
Table 38. Glaxo Smith Kline Meningococcal Conjugate Revenue (US$, Mn), (2017-2022)
Table 39. Hualan Biological Engineering Corporate Summary
Table 40. Hualan Biological Engineering Meningococcal Conjugate Product Offerings
Table 41. Hualan Biological Engineering Meningococcal Conjugate Revenue (US$, Mn), (2017-2022)
Table 42. JN International Medical Corporation Corporate Summary
Table 43. JN International Medical Corporation Meningococcal Conjugate Product Offerings
Table 44. JN International Medical Corporation Meningococcal Conjugate Revenue (US$, Mn), (2017-2022)
Table 45. Baxter International Corporate Summary
Table 46. Baxter International Meningococcal Conjugate Product Offerings
Table 47. Baxter International Meningococcal Conjugate Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Meningococcal Conjugate Product Offerings
Table 50. Merck Meningococcal Conjugate Revenue (US$, Mn), (2017-2022)
Table 51. Serum Institute of India Corporate Summary
Table 52. Serum Institute of India Meningococcal Conjugate Product Offerings
Table 53. Serum Institute of India Meningococcal Conjugate Revenue (US$, Mn), (2017-2022)
Table 54. Biomed Corporate Summary
Table 55. Biomed Meningococcal Conjugate Product Offerings
Table 56. Biomed Meningococcal Conjugate Revenue (US$, Mn), (2017-2022)
Table 57. Novartis Corporate Summary
Table 58. Novartis Meningococcal Conjugate Product Offerings
Table 59. Novartis Meningococcal Conjugate Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Meningococcal Conjugate Segment by Type in 2021
Figure 2. Meningococcal Conjugate Segment by End User in 2021
Figure 3. Global Meningococcal Conjugate Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Meningococcal Conjugate Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Meningococcal Conjugate Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Meningococcal Conjugate Revenue in 2021
Figure 8. By Type - Global Meningococcal Conjugate Revenue Market Share, 2017-2028
Figure 9. By End User - Global Meningococcal Conjugate Revenue Market Share, 2017-2028
Figure 10. By Region - Global Meningococcal Conjugate Revenue Market Share, 2017-2028
Figure 11. By Country - North America Meningococcal Conjugate Revenue Market Share, 2017-2028
Figure 12. US Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Meningococcal Conjugate Revenue Market Share, 2017-2028
Figure 16. Germany Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 17. France Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Meningococcal Conjugate Revenue Market Share, 2017-2028
Figure 24. China Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 28. India Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Meningococcal Conjugate Revenue Market Share, 2017-2028
Figure 30. Brazil Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Meningococcal Conjugate Revenue Market Share, 2017-2028
Figure 33. Turkey Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Meningococcal Conjugate Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Pasteur Meningococcal Conjugate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Meningococcal Conjugate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Glaxo Smith Kline Meningococcal Conjugate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Hualan Biological Engineering Meningococcal Conjugate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. JN International Medical Corporation Meningococcal Conjugate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Baxter International Meningococcal Conjugate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Meningococcal Conjugate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Serum Institute of India Meningococcal Conjugate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Biomed Meningococcal Conjugate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Novartis Meningococcal Conjugate Revenue Year Over Year Growth (US$, Mn) & (2017-2022)